Alliance Pharma (APH)

Company name:Alliance Pharma
EPIC:APHTrading Currency:GBX
Market Sector:ASM6ISIN:GB0031030819
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Ask Open High Low Volume
 67.00 0.0 [0.00] 66.20 67.80 - - - 1,588
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 316.89 472.96 0.02 3.85 1.21 17.40 1.81 71.00 - 44.75

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.316.89m
Shares In Issue472.96m
Prev. Close67.00
PE Ratio17.40 
Dividend Yield1.81%
EPS - basic3.85p
Dividend PS1.21p
Dividend Cover3.18 
Cash Flow PS3.58p
Return On Equity (ROE)10.09%
Operating Margin22.79%
PEG Factor-1.01 
EPS Growth Rate-17.20%
Dividends PS Growth Rate10.00%
Net Debt134.25m
Gross Gearing44.11%
Quick Assets37.10m
Net Working Capital2.18m
Intangibles / Fixed Assets98.71%
Turnover PS20.61p
Pre-Tax Profit PS4.70p
Retained Profit PS2.74p
Cash PS1.53p
Net Cash PS-9.10p
Net Tangible Asset Value PS *-18.09p
Net Asset Value PS37.90p
Spread1.60 (2.36%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week70.0065.20
4 weeks71.0058.00
12 weeks71.0058.00
1 year71.0044.75

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week68.80-1.80-2.6265.200.4567.37
4 weeks68.00-1.00-1.4758.000.6566.36
12 weeks59.008.0013.5658.000.5665.71
26 weeks52.2514.7528.2350.250.5760.49
1 year49.0018.0036.7344.750.9153.37
3 years35.8831.1386.7634.000.6350.37
5 years33.0034.00103.0331.000.4747.10

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio127.15 
PE Ratio17.40 
Tobin's Q Ratio 1.03 
Tobin's Q Ratio (excl. intangibles)7.19 
Dividend Yield1.81%
Market-to-Book Ratio1.77 
Price-to-Pre-Tax Profit PS14.26 
Price-to-Retained Profit PS24.49 
Price-to-Cash Flow PS18.72 
Price-to-Sales PS3.25 
Price-to-Net Tangible Asset Value PS-3.70 
Price-to-Cash PS43.88 
Net Working Capital PS0.46 
Price Pct to Working Capital PS145.56%
Earnings Yield5.75%
Average PE10.53 
Years in average5 
PE to PE average165.34%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio33.72%
Debt-to-Equity Ratio0.51 
Debt-to-Equity Ratio (excl. Intgbl)-1.07 
Debt-to-Equity Market Value0.29 
Net Gearing41.86%
Net Gearing (excl. Intangibles)240.15%
Gross Gearing44.11%
Gross Gearing (excl. Intangibles)253.07%
Gearing Under 1 Year15.68%
Gearing Under 1 Year (excl. Intgbl)89.93%
(Liquidity Ratios)
Net Working Capital to Total Assets0.68%
Current Ratio1.04 
Quick Ratio (Acid Test)0.74 
Liquidity Ratio0.14 
Cash & Equiv/Current Assets13.77%
(Solvency Ratios)
Enterprise Value400.86m
CFO/Attributable Profit0.94 
Total Debt/Equity Market Value0.45 
Total Debt/Sales1.45 
Total Debt/Pre-Tax Profit6.37 
Total Debt141.47m
Total Debt/Net Current Assets64.99%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth6.69%
5 yr Compound Earnings Growth1.30%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)8.22%
Return On Assets (ROA)5.90%
Net Profit Margin18.56%
Assets Turnover0.32 
Return On Equity (ROE)10.09%
Return On Investment (ROI)6.82%
Dividend Payout Ratio31.43%
Plowback Ratio68.57%
Growth from Plowback Ratio7.26%
Net Income Of Revenues13.27%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.57 
Fixed Assets Turnover0.37 
Current Assets Turnover2.37 
Net Working Capital Turnover 
Inventory Turnover6.90 
(Other Operating Ratios)
Total Assets-to-Sales3.14 
Debt Collection Period81.22Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
13 Sep 2017InterimGBX0.4412/31/201612/31/201712/21/201712/22/201701/11/2018-
29 Mar 2017FinalGBX0.8112/31/201512/31/201606/15/201706/16/201707/12/20171.21
14 Sep 2016InterimGBX0.4012/31/201512/31/201612/22/201612/23/201601/12/2017-
07 Apr 2016FinalGBX0.7412/31/201412/31/201506/16/201606/17/201607/13/20161.10
09 Sep 2015InterimGBX0.3612/31/201412/31/201512/24/201512/29/201501/14/2016-
25 Mar 2015FinalGBX0.6712/31/201312/31/201406/18/201506/19/201507/15/20151.00
10 Sep 2014InterimGBX0.3312/31/201312/31/201412/03/201412/05/201401/15/2015-
26 Mar 2014FinalGBX0.6112/31/201212/31/201306/11/201406/13/201407/10/20140.91
11 Sep 2013InterimGBX0.3012/31/201212/31/201312/04/201312/06/201301/15/2014-
21 Mar 2013FinalGBX0.5512/31/201112/31/201206/12/201306/14/201307/11/20130.83
12 Sep 2012InterimGBX0.2812/31/201112/31/201212/05/201212/07/201201/15/2013-
22 Mar 2012FinalGBX0.5012/31/201012/31/201106/13/201206/15/201207/12/20120.75
07 Sep 2011InterimGBX0.2512/31/201012/31/201111/30/201112/02/201101/13/2012-
23 Mar 2011FinalGBX0.4012/31/200912/31/201006/15/201106/17/201107/14/20110.57
08 Sep 2010InterimGBX0.1712/31/200912/31/201012/01/201012/03/201001/14/2011-
24 Mar 2010FinalGBX0.2312/31/200812/31/200906/16/201006/18/201007/15/20100.30
09 Sep 2009InterimGBX0.0712/30/200806/30/200912/02/200912/04/200901/15/2010-

Alliance Pharma Fundamentals

 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
pre tax profit12.0126.39%10.1623.33%15.1831.40%22.2222.79%m
attributable profit9.5821.06%8.3919.26%12.6926.25%18.0918.56%m
retained profit7.5416.58%5.9913.75%10.0520.79%12.9413.27%m
eps - basic (p)3.82 3.17 4.65 3.85 
eps - diluted (p)3.68 3.16 4.55 3.82 
dividends per share0.91 1.00 1.10 1.21 

Alliance Pharma Balance Sheet

 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
fixed assets fixed assets0.590.55%0.400.37%1.010.35%1.810.56%m
intangibles intangibles89.0683.24%88.8882.39%259.9488.96%264.8382.57%m
fixed investments fixed investments0.440.41%1.271.18%1.590.54%1.640.51%m
current assets - other current assets - other--%--%--%--%m
stocks stocks5.475.11%5.915.48%12.914.42%15.364.79%m
debtors debtors10.549.85%9.989.25%13.514.62%29.889.32%m
cash & securities cash & securities0.890.83%1.431.33%3.231.11%7.222.25%m
creditors - short creditors - short14.9513.97%11.4210.58%31.7610.87%50.2815.68%m
creditors - long creditors - long27.3725.59%25.6723.80%98.0033.54%91.2028.43%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves64.6760.44%70.7865.62%162.4455.59%179.2655.89%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
Operating CF10.0311.427.9816.93m
Pre-Financing CF0.128.06-126.398.90m
Retained CF-5.802.432.093.43m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20180221 09:33:34